Wall Street Pulls Back on Novo Nordisk and Jefferies
Stocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...
This intro contrasts SP 500 with target date funds, highlighting flexibility, fees, and potential growth paths relevant to retirement planning.
27,405 articlesStocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...
U.S. stocks drifted midweek as analysts rolled out fresh price targets on key names. Here’s a look at Wednesday’s top...
A wave of fresh research notes on Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesfo...
End your week with clarity. This Friday reads roundup translates market happenings into actionable ideas for your por...
A timely macro rebuttal from Citadel Securities challenges a viral AI-doomsday scenario, arguing that current data sh...
Stocks slip as growth signals and policy expectations shift in early 2026. This report outlines practical tips surviv...
Three dividend-focused ETFs—VYM, SCHD and SPHD—could deliver roughly $7,300 per year from about 690 underlying stocks...
Chips led a broad market dip at midday as investors weighed AI headlines against inflation risks and possible rate hi...
As volatility in Bitcoin keeps traders on edge, JPMorgan analysts argue that cash may be the stabilizer behind a bitc...
Investors often wonder if Nvidia stock should be bought before major AI events. This article breaks down historical p...
When a chief operating officer sells shares, investors often wonder what it really means. This guide explains how to ...
A large insider sale often sparks questions about a company’s future. This article breaks down what the move means, h...